Home / COVID-19 Coverage / URMC testing antiviral drug to treat COVID-19 patients

URMC testing antiviral drug to treat COVID-19 patients

The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of Health to evaluate the safety and effectiveness of antiviral drug remdesivir for adult patients hospitalized with COVID-19. Ann Falsey M.D. and Angela Branche M.D. lead the study alongside the URMC Vaccine Trials and Evaluation Unit (VTEU). Remdesivir ...

Leave a Reply

Your email address will not be published.

x

Check Also

2021 Best Law Firms

The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of ...

Nimish Mohile

Telemedicine use in cancer care increases in pandemic (access required)

The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of ...

Chris Markham

Building a culture of accessibility into your product (access required)

The University of Rochester Medical Center announced today its participation in a clinical trial sponsored by the National Institute of ...